Clinical trial
Brain Imaging in Alzheimer's Disease
NCT00039702 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00039702 |
|---|---|
| Title | Brain Imaging in Alzheimer's Disease |
| Official title | SPECT Imaging of Alpha4beta2 Nicotinic Acetylcholine Receptors Using [123I]5-I-A-85380 in Alzheimer's Disease |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Alzheimer Disease |
| Intervention type | Drug |
| Interventions | [123] 5-I-A-85380 |
| Enrollment | 40 |
| Start date | Jun 1, 2002 |
| Completion | Sep 1, 2004 |
| First posted | Jun 7, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: